The Grant for Oncology Innovation (GOI) is an initiative funded by EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, to identify and support innovative projects to advance research on personalised treatment for solid tumors.
The grant programme was launched to coincide with the European Cancer Congress (ECCO-ESMO-ESTRO) in Amsterdam, September-October, 2013.
The three award winners of the first Grant for Oncology Innovation (GOI) were announced during an Award Ceremony that took place in Madrid on Friday 26 September 2014.
Applications for the 2015 GOI award are now open.
Should you wish to apply for the grant, please send a short message to:
Application deadline: Friday, January 30th, 2015